Glenmark rises on receiving USFDA approval for Levonorgestrel, Ethinyl Estradiol tablets

15 Jun 2015 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 888.35, up by 8.35 points or 0.95% from its previous closing of Rs. 880.00 on the BSE.

The scrip opened at Rs. 889.00 and has touched a high and low of Rs. 893.90 and Rs. 881.30 respectively. So far 12,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 940.00 on 15-Apr-2015 and a 52 week low of Rs. 532.00 on 11-Jul-2014.

Last one week high and low of the scrip stood at Rs. 893.90 and Rs. 832.30 respectively. The current market cap of the company is Rs. 25,128.00 crore.

The promoters holding in the company stood at 48.30% while Institutions and Non-Institutions held 40.84% and 10.85% respectively.

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for the extended-cycle oral contraceptive, Levonorgestrel/Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg, the AB-rated generic version of Seasonale by Teva Women’s Health.

Seasonale is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. According to IMS Health sales data for the 12 month period ending April 2015, the Seasonale market achieved annual sales of approximately $53.7 million.

This approval marks Glenmark’s 12th oral contraceptive and 2nd extended-cycle oral contraceptive authorized for distribution by the USFDA. Glenmark plans to commence shipping of Levonorgestrel/Ethinyl Estradiol Tablets, 0.15 mg/0.03 mg immediately.

Glenmark’s current portfolio consists of 99 products authorized for distribution in the US marketplace and 66 ANDA’s pending approval with the USFDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.


Glenmark Pharma Share Price

1969.30 -16.05 (-0.81%)
16-Dec-2025 11:24 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1787.30
Dr. Reddys Lab 1276.40
Cipla 1506.35
Zydus Lifesciences 920.50
Lupin 2088.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×